Table 3.
List of exosomal miRNA of diagnostic significance identified in lung cancer
| miRNA | Method of Study | Functional Role | References |
|---|---|---|---|
| miR-155, let-7a-2 | miRNA-microarray | Differentiates lung cancer from noncancerous lung tissue | Yanaihara et al. (2006) |
| miR-17-3p, hsa-miR-21, hsa-miR-106a, hsa-miR-146, hsa-miR-155, hsa-miR-191, hsa-miR-192, hsa-miR-203, hsa-miR-205, hsa-miR-210, hsa-miR-212, and hsa-miR-214 | miRNA-microarray | Validation of diagnostic miRNAs | Rabinowits, Gerçel-Taylor, Day, Taylor, and Kloecker (2009) |
| miR-29a-3p and miR-150-5p | Quantitative real-time polymerase chain reaction using Exqon miRNA expression profiling panel | Detection of response of radiotherapy in nonsmall cell lung cancer (NSCLC) | Dinh et al. (2016) |
| miR-21 and miR-155 | miRNA-microarray | Differentiates recurrent tumors from primary tumors | Munagala, Aqil, and Gupta (2016) and Munagala, Aqil, Jeyabalan, and Gupta (2016) |
| miR-30b-5p, 30c-5p, 221-3p, 222-3p | miRNA-microarray | EGFR status | Giallombardo et al. (2016) |
| miR-19b-3p, miR-21-5p, miR-221-3p, miR-409-3p, miR-425-5p, and miR-584-5p | Quantitative real-time polymerase chain reaction using Exqon miRNA expression profiling panel | Biomarkers for lung adenocarcinoma detection | Cui et al. (2018) |
| miR-205-5p and miR-200b | Sequencing | Differentiates patients with lung cancer from patients with pneumonia and pulmonary tuberculosis | Lin et al. (2016) |
| miR-181-5p, miR-30a-3p, miR-30e-3p, and miR-361-5p and let-7, miR-21, miR-24, and miR-486 | Seq | Identify NSCLC adenocarcinoma and squamous cell carcinoma | Jin et al. (2017) |
| miR-21 and miR-4257 | miRNA-microarray | Predictive biomarkers for the recurrence of nonsmall cell lung cancer | Dejima, Iinuma, Kanaoka, Matsutani, and Kawamura (2017) |